Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

4849.0000 -90.00 (-1.82%)

NSE Jul 01, 2025 15:31 PM

Volume: 220.0K

Alkem Laboratories Ltd.

05 Feb 2022

4849.00

-1.82%

Alkem Labs (HOLD): Strong domestic growth; weak margins

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Robust traction in India formulations (+20% YoY) during Q3, partly offset by a 7% decline in US generic revenue

Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.